These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges. Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041 [TBL] [Abstract][Full Text] [Related]
23. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763 [TBL] [Abstract][Full Text] [Related]
24. Transplantation of a New Biological Product in Rare Diseases, Such as Epidermolysis Bullosa: Response and Clinical Outcome. Pliszczyński J; Nita M; Kowalewski C; Woźniak K; Eljaszewicz A; Moniuszko M; Kamiński A; Śladowski D; Zimek Z; Majewski S; Kosieradzki M; Fiedor P Transplant Proc; 2020 Sep; 52(7):2239-2243. PubMed ID: 32334796 [TBL] [Abstract][Full Text] [Related]
25. Integrated Management Strategies for Epidermolysis Bullosa: Current Insights. Sait H; Srivastava S; Saxena D Int J Gen Med; 2022; 15():5133-5144. PubMed ID: 35637703 [TBL] [Abstract][Full Text] [Related]
26. Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa. De Rosa L; Enzo E; Zardi G; Bodemer C; Magnoni C; Schneider H; De Luca M Front Genet; 2021; 12():705019. PubMed ID: 34539738 [TBL] [Abstract][Full Text] [Related]
27. Cellular therapy options for genetic skin disorders with a focus on recessive dystrophic epidermolysis bullosa. Naso G; Petrova A Br Med Bull; 2020 Dec; 136(1):30-45. PubMed ID: 32888294 [TBL] [Abstract][Full Text] [Related]
28. The potential of gene therapy for recessive dystrophic epidermolysis bullosa. Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606 [TBL] [Abstract][Full Text] [Related]
29. Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing. Nita M; Pliszczyński J; Kosieradzki M; Fiedor P Dermatol Ther (Heidelb); 2021 Oct; 11(5):1469-1480. PubMed ID: 34269966 [TBL] [Abstract][Full Text] [Related]
30. Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds. du Rand A; Hunt JMT; Feisst V; Sheppard HM Mol Diagn Ther; 2022 Nov; 26(6):627-643. PubMed ID: 36251245 [TBL] [Abstract][Full Text] [Related]
36. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa. Keith AR; Twaroski K; Ebens CL; Tolar J Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539 [TBL] [Abstract][Full Text] [Related]
37. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Rashidghamat E; McGrath JA Intractable Rare Dis Res; 2017 Feb; 6(1):6-20. PubMed ID: 28357176 [TBL] [Abstract][Full Text] [Related]
38. Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis. Pabón-Carrasco M; Caceres-Matos R; Roche-Campos M; Hurtado-Guapo MA; Ortiz-Romero M; Gordillo-Fernández LM; Pabón-Carrasco D; Castro-Méndez A Healthcare (Basel); 2024 Jan; 12(2):. PubMed ID: 38275540 [TBL] [Abstract][Full Text] [Related]
39. [Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa]. Laimer M; Lanschützer CM; Nischler E; Klausegger A; Diem A; Pohla-Gubo G; Bauer JW; Hintner H Hautarzt; 2009 May; 60(5):378-88. PubMed ID: 19430749 [TBL] [Abstract][Full Text] [Related]